Combined Effect of Web 2086 (Paf Antagonist) and Ketoprofen (Nsaid) on Paf-induced ex vivo Platelet Aggregation in Bovine

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 44, Issue 2, 1997, Pages 65-71

  Bastos Da Silva, M ^a   Herion, F ^b   Raskinet, R ^b   David, J L ^b   Gustin, P ^a   Lekeux, P ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2742522586     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0442.1997.tb01087.x     Document Type: Article

References (21)

1. ADAMUS, W. S., H. HUER, C.J. MEADE, G. FREY, and H.M. BRECHT, 1988: Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex-vivo platelet aggregation. Eur. J. Clin. Pharmacol. 35, 237-240.
2. BASTOS DA SILVA, M., F. HERION, R. RASKINET, J.-L. DAVID, P. GUSTIN, T. GOUGNARD, G. PLOMTEUX, D. DESMECHT, and P. LEKEUX, 1995: Effect of intravenous administration of WEB 2086 on PAF-induced ex-vivo platelet aggregation in healthy Friesian calves. In: Proceedings: XXVth Congress of the World Veterinary Association, Yokohama, Japan, p. 76.
3. BASTOS DA SILVA, M., F. HERION, R. RASKINET, J.-L. DAVID, P. GUSTIN, C. DESSY, and P. LEKEUX, 1996a: Inhibition of PAF-induced platelet aggregation by WEB 2086, an antagonist to the receptor for Platelet-activating factor, in bovine. J. Vet. Med., A., 43, 399-413.
4. BASTOS DA SILVA, M., F. HERION, J.-L. DAVID, P. GUSTIN, M. L. VAN DE WEERDT, and P. LEKEUX, 1996b: Effect of intravenous administration of ketoprofen (NSAID) on PAF-induced bovine platelet aggregation. XIXth World Buiatrics Congress, Edinburg, Scotland, pp. 68-70.
5. BUSSOLINO, F., M. G. PORCELLINI, L. VARESSE, and A. BOSIA, 1987: Intravascular release of platelet activating factor in children with sepsis. Thrombosis Res. 48, 619-620.
6. CAZENAVE, J.-P., and A. BERETZ, 1988: Médicaments inhibiteurs des fonctions plaquettaires, In: Pharmacologie, Michel Schorderet, Ed. Frison-Roche, Paris, pp. 287-298.
7. DAVID, J.-L., F. MONFORT, F. HERION, and R. RASKINET, 1979: Compared effects os three dose-levels of Ticlopodine on platelet function in normal subjects. Thrombosis Res. 14, 35-49.
8. DEMOPOULOS, C. A., R. N. PINCKARD, and D. J. HANAHAN, 1979: Platelet activating factor: evidence for 1 - 0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J. Biol. Chem. 254, 9355-9358.
9. FOSTER, A. P., P. LEES, M. J. ANDREWS, and F. M. CUNNINGHAM, 1992: Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse. Equine Vet. J. 24, 203-207.
10. JOBIN, F., 1995: L'hémostase normale. In: L'hémostase, Les Presses de l'Université Laval, Ed. Maloine, Laval, pp. 3-68.
11. MCALLISTER, C.G., S. J. MORGAN, A. T. BORNE, and R. A. POLLET, 1993: Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J. Am. Vet. Med. Assoc. 202, 71-77.
12. SHPIGEL, N.Y., R. CHEN, M. WINKLER, A. SARAN, G. ZIV, and F. LONGO, 1994: Anti-inflammatory ketoprofen in the treatment of field cases of bovine mastitis. Res. Vet. Sci. 56, 62-68.
13. STEWART, A. G., and G. J. DUSTING, 1988: Characterization of receptores for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Br. J. Pharmacol. 94, 1225-1233.
14. STEWART, A. G., and W. A. PHILLIPS, 1989: Intracellular platelet-activating factor regulates eicosanoid generation in guinea pig resident peritoneal macrophages. Br. J. Pharmacol. 98, 141-148.
15. VAN DE WEERDT, M. L., D. DESMECHT, and P. LEKEUX, 1994: WEB 2086 prevents the PAF-induced pulmonary dysfunctions in calves. In: Proceedings: XVIIIth World Buiatrics Congress, Bologna, Italy, pp. 1239-1242.
16. VARGAFTIG, B. B., and P. BRAQUET, 1987: PAF-acether today - relevance for acute experimental anaphylaxis. Br. Med. Bull. 43, 312-315.
17. VARGAFTIG, B. B., J. LEFORT, M. CHIGNARD, and J. BENVENISTE, 1980: Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur. J. Pharmacol. 65, 185-192.
18. VARGAFTIG, B B., M. CHIGNARD, and J. BENVENISTE, 1981: Present concepts on the mechanism of platelet aggregation. Biochem. Pharmacol. 30, 263-271.
19. VIEIRA, S., 1985: Introdução a Bioestatística. Editora Campus Ltda. 3a. ed. Rio de Janeiro, pp. 223-245.
20. WILSON, D. Y., and J. A. STICK, 1993: Effect of a specific platelet-activating factor antagonist on cardiovascular and peripheral cellular responses to colonic ischemia and reperfusion in anesthetized ponies. Am. J. Vet. Res. 54, 443-448.
21. ZIG, G., and F. LONGO, 1991: Comparative clinical efficacy of ketoprofen and flunixin in the treatment of induced E. coli endotoxin mastitis in lactating dairy cows. In. J. ESPINASSE (ed.) Mammites des Vaches Laitieres, pp. 207-208. Société Française de Buiatrie, Paris.